Owen P. Hughes's most recent trade in C4 Therapeutics Inc was a trade of 35,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| C4 Therapeutics Inc | Owen P. Hughes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 35,500 | 35,500 | - | - | Stock Option (Right to Buy) | |
| XOMA Corp | Owen P. Hughes | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2025 | 53,359 | 168,281 | - | - | Performance Stock Units | |
| XOMA Corp | Owen P. Hughes | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2025 | 53,359 | 88,338 (0%) | 0% | 0 | Common Stock | |
| XOMA Corp | Owen P. Hughes | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 25.38 per share. | 19 May 2025 | 25,637 | 62,701 (0%) | 0% | 25.4 | 650,667 | Common Stock |
| XOMA Corp | Owen P. Hughes | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 53,360 | 56,860 (0%) | 0% | 0 | Common Stock | |
| XOMA Corp | Owen P. Hughes | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 53,360 | 221,640 | - | - | Performance Stock Units | |
| XOMA Corp | Owen P. Hughes | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 29.95 per share. | 11 Nov 2024 | 21,881 | 34,979 (0%) | 0% | 30.0 | 655,336 | Common Stock |
| C4 Therapeutics Inc | Owen P. Hughes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 32,500 | 32,500 | - | - | Stock Option (Right to Buy) | |
| Ikena Oncology Inc | Owen P. Hughes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 17,520 | 17,520 | - | - | Stock Option (Right to Buy) | |
| XOMA Corp | Owen P. Hughes | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2024 | 275,000 | 275,000 | - | - | Performance Stock Units |